Skip to main content
. 2017 Apr 27;116(12):1520–1525. doi: 10.1038/bjc.2017.103

Figure 1.

Figure 1

Sites of oligorecurrences underwent to stereotactic body radiotherapy in the current study. Sites of oligorecurrence: obturator lymph nodes (Ob N)=28 (20.1%); internal iliac lymph nodes (II N)=18 (12.9%); external iliac lymph nodes (EI N)=21 (15.1%); presacral/common iliac lymph nodes (S/CI N)=16 (11.5%); paraortic lymph nodes (PA N)=34 (24.4%); bone=22 (15.8%). A full colour version of this figure is available at the British Journal of Cancer journal online.